Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2006-06-14
2009-06-23
Maier, Leigh C (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S254070, C514S574000
Reexamination Certificate
active
07550445
ABSTRACT:
An aripiprazole formulation is provided which includes the antipsychotic agent aripiprazole in the form of an inclusion complex in a β-cyclodextrin, preferably, sulfobutyl ether β-cyclodextrin (SBECD), which in the form of an injectable produces reversible generally minimal to mild irritation at the intramuscular injection site. A method for minimizing or reducing irritation caused by aripiprazole at an intramuscular injection site and a method for treating schizophrenia employing the above formulation are also provided.
REFERENCES:
patent: 4983586 (1991-01-01), Bodor
patent: 5006528 (1991-04-01), Oshiro et al.
patent: 5134127 (1992-07-01), Stella et al.
patent: 5376645 (1994-12-01), Stella et al.
patent: 5646131 (1997-07-01), Badwan et al.
patent: 5773029 (1998-06-01), Chiesi et al.
patent: 5855916 (1999-01-01), Chiesi et al.
patent: 5904929 (1999-05-01), Uekama et al.
patent: 6232304 (2001-05-01), Kim et al.
patent: 6407079 (2002-06-01), Müller et al.
patent: 6632803 (2003-10-01), Harding
patent: 6713461 (2004-03-01), Billotte
patent: 6977257 (2005-12-01), Parab et al.
patent: 7115587 (2006-10-01), Nerurkar et al.
patent: 2004/0146562 (2004-07-01), Shah
patent: 1 145 711 (2001-10-01), None
patent: 9-301867 (1997-11-01), None
patent: WO 03/026659 (2003-04-01), None
patent: WO 03/064393 (2003-08-01), None
Rajewski, R.A. et al., “Pharmaceutical Applications of Cyclodextrins. 2. In Vivo Drug Delivery”, Journal of Pharmaceutical Sciences, vol. 85, No. 11, 1996, pp. 1142-1169.
Szejtli, J., “Cyclodextrins in Drug Formulations: Part I”, Pharmaceutical Technology International, vol. 3, No. 2, pp. 15-22, (1991).
Szejtli, J. “Cyclodextrins in Drug Formulations: Part II”, Pharmaceutical Technology International, vol. 3, No. 3, pp. 16-24, (1991).
Naringrekar Vijay
Nerurkar Manoj
Bristol--Myers Squibb Company
Levis John F.
Maier Leigh C
Rodney Burton
LandOfFree
Aripiprazole complex formulation and method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aripiprazole complex formulation and method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aripiprazole complex formulation and method will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4061910